We're applying our scientific expertise and proprietary technology to create and deliver next generation RNA therapeutics.
Our development pipeline is focused on three innovative approaches to cancer with high potential to deliver meaningful patient results.
Enhanced In Vivo CAR-T
Our enchanced in vivo CAR-T approach allows treatment to be administered directly into a patient's body making it faster and less expensive to deliver treatments and patient results.
Immuno-oncology
We are developing immuno-oncology treatments to uniquely disrupt the tumor immune microenvironment, harnessing and enhancing the patient’s immune system to recognize and destroy cancer cells in the body.
Cancer Vaccines
We are developing cancer vaccines to precisely activate the patient's immune system to eliminate cancer cells.
Our versatile and unique platform also extends its potential applications
to infectious diseases, genetic disorders and gene therapies.